8-KEarnings & ResultsExhibits & Filings

GILEAD SCIENCES, INC. 8-K Report, Financial Results (Jul 25, 2013)

Filed July 25, 2013For Securities:GILD

Summary

Gilead Sciences, Inc. (GILD) filed an 8-K report on July 25, 2013, to announce its financial results for the second quarter ended June 30, 2013. The report primarily references a press release (Exhibit 99.1) which contains detailed financial information. Investors should note that Gilead presented both GAAP and non-GAAP financial measures, with management believing the non-GAAP figures offer additional insights useful for operational and financial planning. While the 8-K itself does not provide the specific financial figures, it directs investors to the accompanying press release for comprehensive details. This filing serves as a notification of the release of these results and offers a supplemental view of the company's performance through non-GAAP metrics, which are reconciled with GAAP figures in the press release. Investors are encouraged to review the press release for a full understanding of Gilead's financial condition and results of operations for the period.

Key Highlights

  • 1Gilead Sciences announced its Q2 2013 financial results via an 8-K filing on July 25, 2013.
  • 2The filing references a press release (Exhibit 99.1) for detailed financial information.
  • 3Gilead presented financial results on both a GAAP and a non-GAAP basis.
  • 4Management believes non-GAAP measures provide useful insights for investors.
  • 5Non-GAAP information is used internally for operational, budgeting, and financial planning.
  • 6Reconciliation between GAAP and non-GAAP figures is available in the press release.
  • 7The information is furnished, not filed, under Section 18 of the Exchange Act.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially announce Gilead Sciences' financial results for the second quarter ended June 30, 2013, and to provide investors with access to the related press release which contains the detailed financial information.

The specific financial results, including both GAAP and non-GAAP figures, are detailed in the press release issued by Gilead Sciences on July 25, 2013, which is filed as Exhibit 99.1 to this 8-K report.

Gilead presents non-GAAP financial information because management believes it offers useful insights for investors, complementing the standard GAAP financial statements. These non-GAAP measures are also used internally by management for operating, budgeting, and financial planning purposes.

No, the information contained in this Form 8-K and the attached press release is furnished, not filed, for purposes of Section 18 of the Securities Exchange Act of 1934. This means it does not subject Gilead to the liabilities under that section and is not automatically incorporated by reference into other SEC filings.